Trials / Terminated
TerminatedNCT01913301
A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Cardiovascular Clinical Sciences Inc · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to gather information regarding the safety and effectiveness of an investigational drug called Alagebrium when used treating Heart Failure in relation to exercise tolerance after 6 months in the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alagebrium |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2013-08-01
- Last updated
- 2013-08-01
Source: ClinicalTrials.gov record NCT01913301. Inclusion in this directory is not an endorsement.